Publication | Closed Access

Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma

Human PapillomavirusImproved SurvivalHuman Papillomavirus VaccinesSquamous Cell CarcinomaMedicineImmunologyPathologyVirologyHead And Neck Squamous Cell CarcinomaAdult T-cell Leukemia-lymphomaImmunotherapyOncologyViral OncologyCancer ResearchOral CancerCancer-associated Virus